Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Zavicefta“
Suchtreffer
Begriffe & Kennungen
Zavicefta
Eintrag öffnenZavicefta · 4.1 Therapeutic indications · 1
Eintrag öffnenZavicefta · 4.3 Contraindications · 1
Eintrag öffnenZavicefta · 4.3 · Hypersensitivity to any cephalosporin antibacterial agent.
Eintrag öffnenZavicefta · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenZavicefta · 4.3 · Severe hypersensitivity (e.g. anaphylactic reaction, severe skin reaction) to any other type of β-lactam antib
Eintrag öffnenZavicefta · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenZavicefta · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenZavicefta · 4.5 · Avibactam showed no significant inhibition of cytochrome P450 enzymes in vitro. Avibactam and ceftazidime show
Eintrag öffnenZavicefta · 4.5 · Chloramphenicol is antagonistic in vitro with ceftazidime and other cephalosporins. The clinical relevance of
Eintrag öffnenZavicefta · 4.5 · Clinical data have demonstrated that there is no interaction between ceftazidime and avibactam, and between ce
Eintrag öffnenZavicefta · 4.5 · In vitro, avibactam is a substrate of OAT1 and OAT3 transporters which might contribute to the active uptake o
Eintrag öffnenZavicefta · 4.5 · Other types of interaction Concurrent treatment with high doses of cephalosporins and nephrotoxic medicinal pr
Eintrag öffnenZavicefta · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenZavicefta · 4.8 Undesirable effects · 1
Eintrag öffnenZavicefta · 4.8 · * ADR identified post-marketing. a Acute coronary syndrome associated with an allergic reaction.
Eintrag öffnenZavicefta · 4.8 · 11 Table 7: Frequency of adverse reactions by system organ class System organ Very Common Uncommon Very rare N
Eintrag öffnenZavicefta · 4.8 · 12 System organ Very Common Uncommon Very rare Not known class common Erythema multiforme
Eintrag öffnenZavicefta · 4.8 · 13 Reporting of suspected adverse reactions
Eintrag öffnenZavicefta · 4.8 · 3 months of age and older The safety assessment in paediatric patients from 3 months of age and older is based
Eintrag öffnen